Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
Clinical trial NCT05372939 · COMPLETED
Trial details
- NCT number
- NCT05372939
- Sponsor
- Applied Molecular Transport
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-05
- Primary completion
- 2022-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.